Pembrolizumab: New Standard of Care in Head and Neck Cancer Pembrolizumab: New Standard of Care in Head and Neck Cancer

Use of pembrolizumab alone and in combination with chemotherapy has led to significantly improved overall survival in patients with metastatic or recurrent head and neck cancer.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news